ESC 365 - Pathophysiological and therapeutic implications of urocortin-2 in heart failure with preserved ejection fraction

ESC Professional Premium Access

Pathophysiological and therapeutic implications of urocortin-2 in heart failure with preserved ejection fraction

Session: Pathomechanisms of heart failure with preserved ejection fraction

Topic: Heart Failure

Speaker: Miss I. Vasconcelos (Porto, PT)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Miss Ines Vasconcelos

Faculty of Medicine University of Porto, Porto (Portugal)

1 presentation

0 follower

6 more presentations in this session

The histone methyltransferase SETD2 drives cardiometabolic heart failure with preserved ejection fraction

Speaker: Mr S. Ambrosini (Schlieren, CH)

The role of endothelial adipose triglyceride lipase (ecATGL) in heart failure with preserved ejection fraction (HFpEF)

Speaker: Doctor J. Schwanbeck (Berlin, DE)

Alterations in the gut microbiota composition in the obesity phenotype of heart failure with preserved ejection fraction

Speaker: Mr Y. Rokach (Jerusalem, IL)

Induction of periodontitis and oral microbiome dysbiosis in a mouse model with heart failure with preserved ejection fraction results in worsening hypertension and diastolic dysfunction

Speaker: Ms S. Daana (London, GB)

Enhancing NO pathway improves diastolic function in a hamster model of heart failure with preserved ejection fraction associated with nonalcoholic steatohepatitis

Speaker: Doctor C. Dubroca (Escalquens, FR) Doctor F. Briand (FR)

Access the full session

Pathomechanisms of heart failure with preserved ejection fraction

Speakers: Miss I. Vasconcelos, Mr S. Ambrosini, Doctor J. Schwanbeck, Mr Y. Rokach, Ms S. Daana...

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources